Lung Cancer EGFR Antibodies Where is the research going?

Lung Cancer EGFR Antibodies Where is the research going?

thoraciconcology

2 years
276 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses lung cancer EGFR antibodies and where the research is going. His says that immunotherapy is all the rage these days, which is only working on about 20% of the patients. And, as a single-angle frontline, it is only using 50% or more PD-L1 positivity. Depending on the data that will emerge next year or so, EGFR antibodies might have a role, especially on the squamous FISH+ patients. So, clinicians could see the fact that there is another drug that can be used with chemotherapy and hopefully help patients with lung cancer, as well.
Up Next Autoplay